Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving.

Business Wire • Oct 13, 2026

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?

Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.

Zacks Investment Research • Oct 12, 2026

Dividend Champion, Contender, And Challenger Highlights: Week October 4

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Seeking Alpha • Oct 2, 2026

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time.

Business Wire • Oct 1, 2026

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the.

Business Wire • Sep 29, 2026

Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?

Agilent (A) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 25, 2026

Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation

Agilent Technologies NYSE: A executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company's Ignite transformation program, during a J.P. Morgan conference discussion.

MarketBeat • Sep 23, 2026

Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript

Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript

Seeking Alpha • Sep 23, 2026

Top 3 Health Care Stocks That May Keep You Up At Night This Month

As of Sept. 22, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Sep 22, 2026

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequencing.

Business Wire • Sep 21, 2026